SAN DIEGO, Oct. 21, 2024 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in innovation for the health and wellbeing of women, today announced it entered into a 15million commonstockpurchaseagreementandregistrationrightsagreementwith LincolnParkCapitalFund,LLC (“LPC”),a Chicago−basedinstitutionalinvestor.Underthetermsandconditionsofthepurchaseagreement,Dareˊwillhavetheright,fromtimetotimeandatitssolediscretion,tosellupto 15 million of its stock ...